Parenchymal and vascular interactions in the pathogenesis of nonspecific interstitial pneumonia in systemic sclerosis and idiopathic interstitial pneumonia

Respiration

Volumn 76, Issue 2, 2008, Pages 146-153

  Franco De Carvalho, Erika ^a   Parra, Edwin Roger ^a   De Souza, Romy ^a   Muxfeldt A'b Saber, Alexandre ^a   Capelozzi, Vera Luiza ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiogenesis; Fibrosis; Lung; Matrix remodeling; Nonspecific interstitial pneumonia; Systemic sclerosis; Vascular activity

Indexed keywords

VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CELL DENSITY; CLARA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IDIOPATHIC INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS CELL; LUNG BLOOD VESSEL; LUNG DISEASE; LUNG FUNCTION TEST; LUNG PARENCHYMA; MALE; MICROVASCULATURE; NONSPECIFIC INTERSTITIAL PNEUMONIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; SYSTEMIC SCLEROSIS;

ADULT; EPITHELIUM; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 49949089892     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112473     Document Type: Article

References (37)

1. Jimenez SA, Derk CT: Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004;140:37-50.
2. White B: Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 2003;29:371-390
3. Jacobsen S, Ullman S, Shen GQ, et al: Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 2001;28:2454-2459.
4. Steen VD, Medsger TA: Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-2444.
5. Altman RD, Medsger TA, Bloch DA, et al: Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-413.
6. Hubbard R, Venn A:The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology 2002;41:676-679.
7. Steen VD, Conte C, Owens GR, Medsger TA Jr: Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1997;40:1984-1991.
8. American Thoracic Society; European Respiratory Society: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Interstitial Pneumonia. Am J Respir Crit Care Med 2001;165:277-304.
9. Ito I, Nagai S, Kitaichi M, et al: Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005;171:632-638.
10. Douglas WW, Tazelaar HD, Hartman TE, et al: Polymyositis-dermatomyositis associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-1185.
11. Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitaichi M: The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:121-127.
12. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM: Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581-1586.
13. Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, Hansell DM, Nicholson AG: Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585-596.
14. Fujita J, Yamadori I, Suemitsu T, et al: Clinical features of non-specific interstitial pneumonia. Respir Med 1999;93:113-118.
15. White B, Moore WC, Wigley FM, et al: Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Arch Intern Med 2000;132:947-954.
16. Felicio CHC, Parra ER, Capelozzi VL: Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung 2007;185:39-46.
17. Rozin GF, Gomes MM, Parra ER, Kairalla RA, de Carvalho CRR, Capelozzi VL: Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology 2005;46:413-421.
18. Baptista AL, Parra ER, Barbas Filho JV, Kairalla RA, de Carvalho CR, Capelozzi VL: Structural features of epithelial remodeling in usual interstitial pneumonia histologic pattern. Lung 2006;184:239-244.
19. Parra ER, da Costa LRS, Ab'Saber AM, et al: Nonhomogeneous density of CD34 and VCAM-1 alveolar capillaries in major types of idiopathic interstitial pneumonia. Lung 2005;183:363-373.
20. Parra ER, Kairalla RA, de Carvalho CR, Capelozzi VL: Abnormal deposition of collagen-elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias. Thorax 2007;62:428-437.
21. Willis BC, du Bois RM, Borok Z: Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006;3:377-382.
22. Keane MP, Michael P: Inflammation and angiogenesis in fibrotic lung disease. Semin Respir Crit Care Med 2006:27:589-599.
23. Selman M, Talmadge EK Jr, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann Intern Med 2001;134:136-151.
24. Preliminary criteria for the classification of systemic sclerosis (scleroderma): subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590.
25. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-1136.
26. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
27. Gundersen HJ, Bendtsen TF, Korbo L, et al: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988;96:379-394.
28. Katzenstein AL, Fiorelli RF: Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-147.
29. Brown LM, Rannels SR, Rannels DE: Implications of post-pneumonectomy compensatory lung growth in pulmonary physiology and disease. Respir Res 2001;2:340-347.
30. Voswinckel R, Motejl V, Fehrenbach A, Wegmann M, Mehling T, Fehrenbach H, Seeger W: Characterisation of post-pneumonectomy lung growth in adult mice. Eur Respir J 2004;24:524-532.
31. Kasper M, Haroske G: Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 1996;11:463-483.
32. Kawanami O, Ferrans VJ, Crystal RG: Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 1982;46:39-53.
33. Kasper M, Koslowski R, Luther T, Schuh D, Muller M, Wenzel KW: Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis. Histochem Cell Biol 1995;104:397-405.
34. Kallenberg CG, Schilizzi BM, Beaumont F, De Leij L, Poppema S, The TH: Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. J Clin Pathol 1987;40:725-733.
35. Masahito E, Minoru S, Naoko S, Yuichiro K, Takashi S, Mareyuki E, Hironobu S, Takashi K, Toshihiro N: Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004;169:1203-1208.
36. Abonia JP, Hallgren J, Jones T, Shi T, Xu Y, Koni P, Flavell RA, Boyce JA, Austen KF, Gurish MF: α-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood 2006;108:1588-1594.
37. Bevilacqua MP: Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.